Erika Driver-Dunckley1, Charles H Adler2, Joseph G Hentz3, Brittany N Dugger4, Holly A Shill4, John N Caviness2, Marwan N Sabbagh4, Thomas G Beach4. 1. Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. Electronic address: driverdunckley.erika@mayo.edu. 2. Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. 3. Biostatistics Section, Mayo Clinic, Scottsdale, AZ, USA. 4. Banner Sun Health Research Institute, Sun City, AZ, USA.
Abstract
BACKGROUND: Olfactory dysfunction in Parkinson's disease (PD) is well-established and may represent one of the earliest signs of the disease. OBJECTIVE & METHODS: The objective of this study was to evaluate the relationship of olfactory dysfunction, using the University of Pennsylvania Smell Identification Test (UPSIT), to clinical and pathological parameters of clinicopathologically diagnosed PD (n = 10), incidental Lewy body disease (ILBD) (n = 13), and identically assessed controls who lacked a neurodegenerative disease (n = 69). RESULTS: Mean UPSIT scores were significantly lower in PD (16.3, p < 0.001) and ILBD (22.2, p = 0.004) compared to controls (27.7). Using an UPSIT cutoff score of <22 (the 15th percentile) the sensitivity for detecting PD was 9/10 (90%) and ILBD 6/13 (46%), while the specificity was 86% (Controls with score of <22 = 10/69). CONCLUSIONS: These results add to the growing body of evidence suggesting that olfactory testing could be useful as a screening tool for identifying early, pre-motor PD.
BACKGROUND:Olfactory dysfunction in Parkinson's disease (PD) is well-established and may represent one of the earliest signs of the disease. OBJECTIVE & METHODS: The objective of this study was to evaluate the relationship of olfactory dysfunction, using the University of Pennsylvania Smell Identification Test (UPSIT), to clinical and pathological parameters of clinicopathologically diagnosed PD (n = 10), incidental Lewy body disease (ILBD) (n = 13), and identically assessed controls who lacked a neurodegenerative disease (n = 69). RESULTS: Mean UPSIT scores were significantly lower in PD (16.3, p < 0.001) and ILBD (22.2, p = 0.004) compared to controls (27.7). Using an UPSIT cutoff score of <22 (the 15th percentile) the sensitivity for detecting PD was 9/10 (90%) and ILBD 6/13 (46%), while the specificity was 86% (Controls with score of <22 = 10/69). CONCLUSIONS: These results add to the growing body of evidence suggesting that olfactory testing could be useful as a screening tool for identifying early, pre-motor PD.
Authors: Charles H Adler; Donald J Connor; Joseph G Hentz; Marwan N Sabbagh; John N Caviness; Holly A Shill; Brie Noble; Thomas G Beach Journal: Mov Disord Date: 2010-04-15 Impact factor: 10.338
Authors: G Webster Ross; Robert D Abbott; Helen Petrovitch; Caroline M Tanner; Daron G Davis; James Nelson; William R Markesbery; John Hardman; Kamal Masaki; Lenore Launer; Lon R White Journal: Mov Disord Date: 2006-12 Impact factor: 10.338
Authors: Andrew Siderowf; Danna Jennings; Shirley Eberly; David Oakes; Keith A Hawkins; Albert Ascherio; Matthew B Stern; Kenneth Marek Journal: Mov Disord Date: 2012-01-11 Impact factor: 10.338
Authors: Thomas G Beach; Charles L White; Christa L Hladik; Marwan N Sabbagh; Donald J Connor; Holly A Shill; Lucia I Sue; Jeanne Sasse; Jyothi Bachalakuri; Jonette Henry-Watson; Haru Akiyama; Charles H Adler Journal: Acta Neuropathol Date: 2008-11-04 Impact factor: 17.088
Authors: Thomas G Beach; Lucia I Sue; Douglas G Walker; Alex E Roher; LihFen Lue; Linda Vedders; Donald J Connor; Marwan N Sabbagh; Joseph Rogers Journal: Cell Tissue Bank Date: 2008-03-18 Impact factor: 1.522
Authors: Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh Journal: J Parkinsons Dis Date: 2016 Impact factor: 5.568
Authors: Sukriti Nag; Lei Yu; Veronique G VanderHorst; Julie A Schneider; David A Bennett; Aron S Buchman; Robert S Wilson Journal: J Neurol Date: 2019-09-18 Impact factor: 4.849
Authors: Diego Iacono; Maria Geraci-Erck; Marcie L Rabin; Charles H Adler; Geidy Serrano; Thomas G Beach; Roger Kurlan Journal: Neurology Date: 2015-10-14 Impact factor: 9.910
Authors: Charles H Adler; Brittany N Dugger; Joseph G Hentz; Michael L Hinni; David G Lott; Erika Driver-Dunckley; Shyamal Mehta; Geidy Serrano; Lucia I Sue; Amy Duffy; Anthony Intorcia; Jessica Filon; Joel Pullen; Douglas G Walker; Thomas G Beach Journal: Mov Disord Date: 2016-01-22 Impact factor: 10.338
Authors: Charles H Adler; Thomas G Beach; Nan Zhang; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Shyamal H Mehta; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Christine M Belden; Jessica Powell; Sandra A Jacobson; Edward Zamrini; David Shprecher; Kathryn J Davis; Brittany N Dugger; Joseph G Hentz Journal: J Neuropathol Exp Neurol Date: 2019-10-01 Impact factor: 3.685